Popular Antidepressants May Put Patients At Risk For Serious Arrhythmias

In August 2011 the FDA issued a safety communication recommending that the extremely popular antidepressant citalopram (Celexa) not be used at doses greater than 40 mg/day because of a potential increased risk for serious cardiac arrhythmias associated with prolongation of the QT interval. Now a study published in BMJ lends support to this warning and suggests that other antidepressants may also prolong the QT interval. Click here to read the complete story on Forbes.  

Source: CardioBrief - January 29, 2013 Category: Cardiology Authors: Larry Husten Tags: Uncategorized Antidepressant BMJ Citalopram FDA food and drug administration Selective serotonin reuptake inhibitor Source Type: blogs